GSM9457800: PB LILRB2 treatment; Homo sapiens; RNA-Seq
SK-MEL-5 tumors were dissected from humanized mice treated with either isotype control antibody or anti-LILRB2 antibody and single-cell suspensions were obtained. Live, single, tumor-infiltrating immune cells were enriched by FACS. Cells were counted and loaded onto the Chromium Controller (10x Genomics, RRID: SCR_019326). Samples were processed as per manufacturer's instruction and sequenced on an Illumina NextSeq 500 sequencer (RRID:SCR_014983).